A recent case report published in Cureus identifies a temporal association between Co-amoxiclav exposure and new-onset manic-spectrum symptoms.
The study highlights the importance of monitoring psychiatric side effects in patients prescribed this common antibiotic.
Researchers recommend further clinical investigation to determine the underlying mechanism linking the medication to these behavioral changes.